(Q51027323)

English

In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system.

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system. (English)

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

1 reference

based on heuristic

inferred from title

Friedrich Altmann

7

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

author name string

Manfred Schuster

1

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Wolfgang Jost

2

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Geert C Mudde

3

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Susanne Wiederkum

4

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Cornelia Schwager

5

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Evelyne Janzek

6

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Johannes Stadlmann

8

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Christian Stemmer

9

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Gilbert Gorr

10

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

publication date

1 June 2007

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Biotechnology Journal

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

2

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

700-708

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

6

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1074/JBC.M202069200

Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/JCP.1041400219

Identifiers

10.1002/BIOT.200600255

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/17427997

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51027323&oldid=1647569942"